Getting balance: Drugs for bipolar disorder share target (original) (raw)

Nature Medicine volume 8, pages 557–558 (2002)Cite this article

Lithium and anticonvulsants such as valproic acid have the same end result: a more stable life for people with bipolar disorder. Now it seems they may also affect the same biochemical pathway in the brain.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Figure 1: Intracellular signaling cascades involved in long term stabilization of mood by lithium (Li) and valproic acid (VPA).

Kimberly Homer

References

  1. Williams, R.S.B, Cheng, L., Mudge, A.W., Harwood, A.J. A common mechanism of action for three mood-stabilizing drugs. Nature, 417 292–295 (2002).
    Article CAS Google Scholar
  2. Berridge, M.J., Downes, C.P. & Hanley, M.R. Neural and developmental actions of lithium: A unifying hypothesis. Cell. 59, 411–419 (1989).
    Article CAS Google Scholar
  3. Manji, H.K. & Chen, G. PKC, MAP kinases and the bcl-2 family of proteins as long term targets for mood stabilizers. Mol. Psychiatry 7, S46–56 (2002).
    Article CAS Google Scholar
  4. Lenox, R.H. & Hahn, C.G. Overview of the mechanism of action of lithium in the brain: Fifty-year update. J. Clin. Psychiatry. 61 (Suppl. 9), 5–15 (2000).
    CAS PubMed Google Scholar
  5. Niculescu, A.B. 3rd & Kelsoe, J.R. Convergent functional genomics: Application to bipolar disorder. Ann Med. 33, 263–271 (2001).
    Article CAS Google Scholar
  6. Klein, P.S. & Melton, D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8455–8459 (1996).
    Article CAS Google Scholar
  7. Maes, M. et al. Alterations in plasma prolyl endopeptidase activity in depression, mania and schizophrenia; effects of antidepressants, mood stabilizers and antipsychotic drugs. Psychiatry Res. 58, 217–225 (1995).
    Article CAS Google Scholar
  8. Duman, R.S. Synaptic plasticity and mood disorders. Mol. Psychiatry 7, 29–34 (2002).
    Article Google Scholar
  9. Drevets, W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 11, 240–249 (2001).
    Article CAS Google Scholar
  10. Chen, G., Einat, H., Yuan, P. & Manji, H.K. Evidence for the involvement of the MAP/ERK signaling cascade in mood modulation. Biol. Psychiatry (in the press).
  11. Tsai, G. & Coyle, J.T. _N_-acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 46, 531–540 (1995).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. McLean Department of Psychiatry Harvard Medical School, Belmont, Massachusetts, USA
    Joseph T. Coyle
  2. National Institute of Mental Health, Bethesda, Maryland, USA
    Husseini K. Manji

Authors

  1. Joseph T. Coyle
    You can also search for this author inPubMed Google Scholar
  2. Husseini K. Manji
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Coyle, J., Manji, H. Getting balance: Drugs for bipolar disorder share target.Nat Med 8, 557–558 (2002). https://doi.org/10.1038/nm0602-557

Download citation